PALVELLA THERAPEUTICS INC (PVLA) Stock Balance Sheet
NASDAQ:PVLA - US6979471090 - Common Stock
58.45 USD
-1.28 (-2.14%)
58.45 USD
0 (0%)
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 75.63M | 83.60M | 17.40M | 38.63M | 117.76M | |||
| Marketable Securities | N/A | N/A | 8.97M | 20.53M | N/A | |||
| Receivables | 1.98M | 2.34M | 6.04M | 5.81M | 3.31M | |||
| Other Current Assets | 1.83M | 2.30M | 6.28M | 8.45M | 6.55M | |||
| Total Current Assets | 79.44M | 88.23M | 38.68M | 73.42M | 127.63M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | N/A | 0.00 | 20.70M | 23.03M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | N/A | N/A | 0.00 | 1.37M | 2.90M | |||
| Total Non-Current Assets | 0.00 | 0.00 | 0.00 | 22.07M | 25.93M | |||
| TOTAL ASSETS | 79.44M | 88.23M | 38.68M | 95.49M | 153.56M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 1.74M | 5.47M | 8.19M | 11.12M | 14.83M | |||
| Accounts Payable | 4.44M | 4.59M | 3.37M | 4.15M | 8.61M | |||
| Other Current Liabilities | 2.80M | 1.98M | 363.00K | 21.31M | 27.12M | |||
| Total Current Liabilities | 8.98M | 12.04M | 11.92M | 36.58M | 50.56M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 14.88M | 13.59M | 0.00 | 30.98M | 52.24M | |||
| Total Non-Current Liabilities | 14.88M | 13.59M | 0.00 | 30.98M | 52.24M | |||
| TOTAL LIABILITIES | 23.86M | 25.63M | 11.92M | 67.56M | 102.81M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -101.92M | -93.73M | -314.96M | -290.42M | -257.14M | |||
| Additional Paid In Capital | 157.49M | 156.33M | 341.60M | 318.53M | 307.00M | |||
| Common Shares | 11.00K | 11.00K | 98.00K | 74.00K | 72.00K | |||
| Other Shareholders' Equity | -3.00K | 3.00K | 28.00K | -254.00K | 829.00K | |||
| Shares Outstanding | 11.02M | 11.01M | 1.24M | 931.00K | 903.00K | |||
| Tangible Book Value per Share | 5.04 | 5.69 | 21.63 | 30.00 | 56.21 | |||
| Total Shareholders' Equity | 55.58M | 62.61M | 26.76M | 27.93M | 50.76M | |||
| TOTAL LIABILITIES AND EQUITY | 79.44M | 88.23M | 38.68M | 95.49M | 153.56M | |||
| Statistics | ||||||||
| Current Ratio | 8.84 | 7.33 | 3.24 | 2.01 | 2.52 | |||
| Return On Assets (ROA) | -27.07% | -19.27% | -63.45% | -34.85% | -29.79% | |||
| Return On Equity (ROE) | -38.70% | -27.15% | -91.72% | -119.15% | -90.12% | |||
All data in USD , ROIC based on taxRate of 0.21